Mindfulness-based Cognitive Therapy vs the Health Enhancement Program for Chronic Pain and Depres… (NCT07118722) | Clinical Trial Compass
RecruitingNot Applicable
Mindfulness-based Cognitive Therapy vs the Health Enhancement Program for Chronic Pain and Depression; The Quiet Focus Study
United States60 participantsStarted 2025-09-01
Plain-language summary
The goal of this clinical trial is to pilot a randomized controlled trial comparing an adaptation of mindfulness-based cognitive therapy to the health enhancement program for chronic pain and depression. The main questions it aims to answer in a later fully powered randomized controlled trial are:
* Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life?
* Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?
Who can participate
Age range50 Years – 120 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Older adult (age ≥ 50)
✓. All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa
✓. Pain in muscles, joints, bones, or associated soft tissues (NRS\>4) lasting longer than 3 months
✓. Depressed (PHQ-9 score of 5-14)
✓. English fluency/literacy
✓. Ability and willingness to participate via in-person and video
✓. No change to type or dose of antidepressant medications for at least 6 weeks prior to screening
✓. Willing to provide informed consent and comply with all aspects of the protocol
Exclusion criteria
✕. Moderately severe or severe depressive symptoms (PHQ-9 ≥ 15)
✕. Current substance abuse/dependence
What they're measuring
1
The Credibility and Expectancy Questionnaire
Timeframe: From enrollment to 3 months from the end of treatment at 8 weeks
2
The Client Satisfaction Questionnaire
Timeframe: Administered at the end of treatment at 8 weeks and at the three month follow up visit
3
Modified Patient Global Impression of Change
Timeframe: At end of 8 week program (post test) and again at 3 month follow up visit